Evidence map›Paper›PMID 22353746›Full record

ArticleOsteoarthritis and cartilage2012

DIO2 modifies inflammatory responses in chondrocytes.

A W M Cheng, M Bolognesi, V B Kraus

Open access · greenAbstract read
In one paragraph

Article in Osteoarthritis and cartilage, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trace Elements-Role in Joint Function and Impact on Joint Diseases.International journal of molecular sciences · 2025
    Review
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Relationship between selenium status, selenoproteins and COVID-19 and other inflammatory diseases: A critical review.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Role of adipose tissue in facial aging.Clinical interventions in aging · 2017
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

A W M ChengDepartment of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
M BolognesiDepartment of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
V B KrausDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: vbk@duke.edu.
Duke Medical Center · USDuke University Hospital · US

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Virginia B Kraus · 2006 to 2026
$24.6M
University Training Program in Biomolecular & Tissue EngineeringT32GM008555 · NIGMS · DUKE UNIVERSITY · PI GERSBACH, CHARLES A. · 1994 to 2021
$8.1M
Determination of OA Pathology by Biomarker DatingU01AR050898 · NIAMS · DUKE UNIVERSITY · PI KRAUS, VIRGINIA B. · 2003 to 2007
$1.2M
NIAMS NIH HHS U01 AR050898NIA NIH HHS 5P30 AG028716NIA NIH HHS P30 AG028716NIGMS NIH HHS T32 GM00855-15NIGMS NIH HHS T32 GM00855-16NIGMS NIH HHS T32 GM008555
6 · The paper itself

Abstract

objectiveSelenium neutralizes interleukin-1β (IL-1β) induced inflammatory responses in chondrocytes. We investigated potential mechanisms for this through in vitro knock down of three major selenoproteins, Iodothyronine Deiodinase-2 (DIO2), Glutathione Peroxidase-1 (GPX1), and Thioredoxin Reductase-1 (TR1) in primary human chondrocytes.

methodsPrimary human chondrocytes were transfected with scrambled small interfering ribonucleic acid (siRNA) or siRNA specific for DIO2, GPX1 and TR1. After 48 h, transfected cells were cultured in serum free media for 48 h, with or without 10 pg/ml IL-1β for the final 24h. The efficiency of siRNAs was confirmed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot analysis. The gene expression, by qRT-PCR, of cyclooxygenase-2 (COX2), IL-1β, and Liver X receptor (LXR) alpha and beta was evaluated to determine the impact of selenoprotein knockdown on inflammatory responses in chondrocytes.

resultsThe messenger RNA (mRNA) expression of DIO2, GPX1, and TR1 was significantly decreased by the specific siRNAs (reduced 56%, P=0.0004; 96%, P<0.0001; and 66%, P<0.0001, respectively). Suppression of DIO2, but not GPX1 or TR1, significantly increased (~2-fold) both basal (P=0.0005) and IL-1β induced (P<0.0001) COX2 gene expression. Similarly, suppression of DIO2 significantly increased (∼9-fold) IL-1β induced IL-1β gene expression (P=0.0056) and resulted in a 32% (P=0.0044) decrease in LXRα gene expression but no effect on LXRβ.

conclusionsSuppression of the selenoprotein DIO2 resulted in strong pro-inflammatory effects with increased expression of inflammatory mediators, IL-1β and COX2, and decreased expression of LXRα suggesting that this may be the upstream target through which the anti-inflammatory effects of DIO2 are mediated.

Indexed as

Cells, CulturedChondrocytesCyclooxygenase 2Gene Expression RegulationGene Knockdown TechniquesGlutathione PeroxidaseGlutathione Peroxidase GPX1HumansInflammation MediatorsInterleukin-1betaIodide PeroxidaseIodothyronine Deiodinase Type IILiver X ReceptorsOrphan Nuclear ReceptorsRNA, Small InterferingThioredoxin Reductase 1Cyclooxygenase 2Glutathione PeroxidaseGlutathione Peroxidase GPX1GPX1 protein, humanInflammation MediatorsInterleukin-1betaIodide PeroxidaseIodothyronine Deiodinase Type IILiver X ReceptorsNR1H3 protein, humanOrphan Nuclear ReceptorsPTGS2 protein, humanRNA, Small InterferingThioredoxin Reductase 1TXNRD1 protein, human

Identifiers

PMID22353746
PMCPMC3322270
OpenAlexW1965854455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.